首页> 外文OA文献 >Risk Management for Patients Receiving Ticlopidine Hydrochloride and its Evaluation-Proper Use of Ticlopidine in Patients after Percutaneous Coronary Intervention (PCI)-

【2h】

Risk Management for Patients Receiving Ticlopidine Hydrochloride and its Evaluation-Proper Use of Ticlopidine in Patients after Percutaneous Coronary Intervention (PCI)-

机译：盐酸噻吩丙氨酸酸酐患者的风险管理及其在经皮冠状动脉介入后患者噻吩妥的评价 - 适当使用（PCI） -

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yukari Kawamoto; Naohiro Ohshita; Yoshikazu Gotoh; Shinzi Iwai; Katsumi Itoh; Kohji Tadano; Noriyoshi Katoh;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients A Double-Blind Randomized Study [J] . Pietro Di Pasquale, Sergio Cannizzaro, Sebastiano Scalzo, Heartdrug: excellence in cardiovascular trials . 2005,第4期

机译：高危患者经皮冠状动脉介入治疗后噻氯匹定和阿司匹林与氯吡格雷和阿司匹林的比较双盲随机研究
2. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score [J] . JACC. Cardiovascular interventions . 2012,第11期

机译：经皮冠状动脉介入治疗的急性冠脉综合征患者危险分层的新评分：ACUITY-PCI（急性导管插入和紧急干预分类策略-经皮冠状动脉介入治疗）风险评分
3. Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention [J] . NakayamaA., MoritaH., AndoJ., Heart and vessels: An international journal . 2013,第3期

机译：经皮冠状动脉介入治疗患者同时使用氯吡格雷或噻氯匹定和质子泵抑制剂相关的不良心血管预后
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Impact of Hospital Volume of Percutaneous Coronary Intervention (PCI) on In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based on the 2014 Cohort of the Korean Percutaneous Coronary Intervention (K-PCI) Registry [O] . Byong-Kyu Kim, Deuk-Young Nah, Kang Un Choi, 2020

机译：医院体积的经皮冠状动脉干预（PCI）对急性心肌梗死患者的医院结果：基于2014年韩国经皮冠状动脉介入（K-PCI）登记处的群组
7. A New Score for Risk Stratification of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention The ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy–Percutaneous Coronary Intervention) Risk Score [O] . Palmerini Tullio, Genereux Philippe, Caixeta Adriano, 2012

机译：经皮冠状动脉介入治疗的急性冠脉综合征患者风险分层的新评分ACUITY-PCI（急性导管插入和紧急干预分类策略-经皮冠状动脉介入治疗）风险评分

Risk Management for Patients Receiving Ticlopidine Hydrochloride and its Evaluation-Proper Use of Ticlopidine in Patients after Percutaneous Coronary Intervention (PCI)-

著录项

引文网络

相似文献

相关主题

期刊订阅